Today: 30 April 2026
Browse Category

NASDAQ:FOSL 23 August 2025 - 16 October 2025

Fossil Group (FOSL) Stock’s Wild 2025 Ride: Skyrockets on Turnaround Hopes, Stumbles on Debt Fears

Fossil Group (FOSL) Stock’s Wild 2025 Ride: Skyrockets on Turnaround Hopes, Stumbles on Debt Fears

Fossil Group shares jumped over 40% to $3.75 on Oct. 15 after reporting a surprise profit and India IPO rumors, then fell 40% the next day on renewed debt concerns. Year-to-date, the stock is up 62%, far outpacing industry peers. The company is restructuring $150 million in debt and exploring a $300–$400 million India unit IPO. Q2 results showed a swing to $8.5 million operating profit despite a 16% sales drop.
16 October 2025
·
2025’s Most Popular Men’s and Women’s Watches – Luxury Icons, Smartwatch Superstars, Fashion Favorites & Affordable Gems

2025’s Most Popular Men’s and Women’s Watches – Luxury Icons, Smartwatch Superstars, Fashion Favorites & Affordable Gems

Swiss watch exports hit a record CHF 26.7 billion in 2023. Rolex surpassed CHF 10 billion in annual revenue, selling about 1.24 million watches and capturing 30% of the market. The Big Four brands account for nearly 44% of Swiss watch market value. Smartwatches reached 455 million users worldwide, with Apple holding a 21% share.
23 August 2025
······

Stock Market Today

  • Bristol Myers Squibb Shares Surge 5% on Strong Q1 Sales Growth
    April 30, 2026, 5:46 PM EDT. Bristol Myers Squibb's stock jumped over 5% after the company reported a 3% rise in first-quarter revenue to $11.5 billion, driven by a 12% sales increase in its growth portfolio. Despite a decline in non-GAAP net income to $3.2 billion, the firm beat Wall Street estimates of $1.42 per share adjusted earnings. The growth portfolio, excluding the cancer drug Opdivo, saw broad sales gains, while the legacy portfolio mostly declined except for blood thinner Eliquis. Management reaffirmed 2026 guidance with revenues projected between $46 billion and $47.5 billion, and adjusted earnings per share forecasted at $6.05 to $6.35. Investors responded positively, underpinning Bristol Myers Squibb's profile as a dynamic name in pharmaceuticals.

Latest article

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

Nvidia Stock Falls as Google and Amazon AI Chip Push Tests the AI Trade

30 April 2026
Nvidia shares dropped 4.6% to $199.57 Thursday as investors reacted to Alphabet and Amazon expanding sales of their own AI chips. Alphabet reported Google Cloud revenue up 63% and began selling TPU chips directly to customers. AMD and Broadcom shares rose 5.1% and 3.0%, respectively. Amazon said its Trainium chip line secured $225 billion in revenue commitments.
US Stock Market After Hours: Apple Earnings Put Record Rally to the Test

US Stock Market After Hours: Apple Earnings Put Record Rally to the Test

30 April 2026
The S&P 500 and Nasdaq closed at record highs Thursday, finishing their strongest month in years. Apple fell about 1% after hours despite beating revenue and profit estimates, as iPhone sales missed forecasts. The Dow rose 1.62% to 49,652.14. Oil prices and AI spending remain key risks to the rally.
SiriusXM Stock Moves on Subscriber Surprise as Cash Flow Jumps

SiriusXM Stock Moves on Subscriber Surprise as Cash Flow Jumps

30 April 2026
Sirius XM Holdings lost 111,000 self-pay subscribers in Q1, far fewer than analysts expected, sending shares up 0.9% to $27.01. Revenue rose 1% to $2.09 billion, with net income up 20% to $245 million. Podcast revenue jumped 37%. SiriusXM ended the quarter with 32.8 million subscribers, down from 32.9 million a year earlier.
Go toTop